Botox

Neurotoxin

onabotulinumtoxinA

Recorded history of Botox — FDA records, PCAC review history, and state overlays. Each entry links to its source; entries marked reported rest on reported sources; source classification alone does not authenticate a vote tally.

Licensed biologic context. FDA’s Purple Book lists Botox / Botox Cosmetic (onabotulinumtoxinA), BLA 103000, under section 351(a). FDA explains that biological products are not eligible for the compounded-drug exemptions under sections 503A and 503B; separate FDA guidance addresses certain mixing, dilution and repackaging outside approved labeling.

FDA Purple Book ↗ · FDA compounding Q&A ↗

Tracker collector’s last successful poll: not available on this public page. The aggregate polling signal on the tracker index covers multiple sources.

Per-substance authority reconciliation: no documented date is provided here. A recent source event or poll does not establish complete coverage of FDA updates.

Source-event dates and recent source polls do not establish that each substance’s current eligibility has been reverified.

We do not sell, source, or supply Botox. This is a monitoring record from public government sources — not a product, and not advice.

Federal history

No MSR event recorded in the published federal history for Botox. This is a gap in this tracker’s record, not evidence that no federal position or source exists.

State overlays

No MSR event recorded in the published state history for Botox. State boards hold independent authority; legislation is monitored via LegiScan and board positions are added as they are verified.

Track Botox changes

Get the free weekly Brief — FDA and state moves on peptide & GLP-1 compounding, with the source and the date. Members are alerted for their states as soon as a change is published.

Get the free Brief →

← All substances · Informational monitoring from public government sources — not legal or medical advice. No efficacy claims.

Get regulatory changes as they publish

We scan all 50 state legislatures daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address